valeantpharmaceuticals documents

4 q13 presentation final
Investor Relations 4 q13 presentation final
Q2 2013 Financial Results
Business Q2 2013 Financial Results
20140528 valeant story draft deckv85
Investor Relations 20140528 valeant story draft deckv85
6.02.14 final improved offer deck final3
Investor Relations 6.02.14 final improved offer deck final3
3 q13 presentation final final2
Business 3 q13 presentation final final2
2 q14 presentation draft final
Investor Relations 2 q14 presentation draft final
Jpm presentation 2013 final final
Documents Jpm presentation 2013 final final
3 q12 presentationfinal2
Documents 3 q12 presentationfinal2
3 q12 presentation final
Documents 3 q12 presentation final
Valeant Pharmaceuticals' Investor Day 2012 Download
Business Valeant Pharmaceuticals' Investor Day 2012 Download
Guidance presentation jan 2014 final
Business Guidance presentation jan 2014 final
Guidance presentation jan 2013 final
Documents Guidance presentation jan 2013 final
Valeant Pharmaceuticals Correct Recent Misrepresentations
Investor Relations Valeant Pharmaceuticals Correct Recent Misrepresentations
1 q14 presentation final2
Investor Relations 1 q14 presentation final2
4Q 2012 Presentation
Investor Relations 4Q 2012 Presentation
Q1 2013 Financial Results Conference Call
Business Q1 2013 Financial Results Conference Call
Pro Forma EBITDA Reconciliation
Documents Pro Forma EBITDA Reconciliation
Bausch + Lomb Acquisition Conference Call
Documents Bausch + Lomb Acquisition Conference Call
3 q14 presentation
Investor Relations 3 q14 presentation
Jpm 2014
Economy & Finance Jpm 2014
Guidance presentation jan 2015 final2
Business Guidance presentation jan 2015 final2